Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06597747 · ClinicalTrials.gov registry record · NA
Design Improvements With SONNET 3
A NA study, sponsored by Med-El Corporation.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT06597747: Completed NA study, sponsored by Med-El Corporation.
NCT06597747 is a NA study that has completed, run by Med-El Corporation. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06597747, a NA study, has completed, sponsored by Med-El Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Measuring user-reported satisfaction with the latest behind-the-ear (BTE) audio processor model.
Primary Outcome
The proportion of participants reporting improvement in design aspects of SONNET 3 (EAS) on a user survey
Interventions
- DEVICE Audio processor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-12-16 |
| Est. Completion | 2025-07-31 |
| Phase | NA |
What the finished NCT06597747 record still lists
NCT06597747 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Audio processor is the first listed.
NCT06597747 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06597747 about?
NCT06597747 is a clinical study titled "Design Improvements With SONNET 3". Measuring user-reported satisfaction with the latest behind-the-ear (BTE) audio processor model.
What is the current status of trial NCT06597747?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2024-12-16. Estimated completion is 2025-07-31.
What interventions are being tested in trial NCT06597747?
The interventions under investigation include: Audio processor (DEVICE).
Who is sponsoring clinical trial NCT06597747?
This trial is sponsored by Med-El Corporation, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06597747's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI